{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:23:41Z","timestamp":1784874221014,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01498-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:59:51Z","timestamp":1764604791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A commentary on the article \u201cControlled Ovarian Stimulation (COS) with follitropin delta results in higher cumulative live birth rates compared with r-hFSH alfa\/beta in a large retrospectively analysed real-world data set\u201d"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1220-410X","authenticated-orcid":false,"given":"Susana","family":"Montenegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Enrique","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12958-025-01364-5","volume":"23","author":"TK Eggersmann","year":"2025","unstructured":"Eggersmann TK, Sch\u00fctt M, Becker J, Kimmel M, Aust H, Winkler J, Freis A. Controlled ovarian stimulation (COS) with follitropin delta results in higher cumulative live birth rates compared with follitropin alfa\/beta in a large retrospectively analyzed real-world data set. Reprod Biol Endocrinol. 2025;23:25.","journal-title":"Reprod Biol Endocrinol"},{"key":"1498_CR2","unstructured":"REKOVELLE, INN-follitropin delta. Summary of product characteristics.\u00a0https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/rekovelle-epar-product-information_en.pdf."},{"key":"1498_CR3","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0015-0282(97)00507-4","volume":"69","author":"Z Ben-Rafael","year":"1998","unstructured":"Ben-Rafael Z, Levy T, Schoemaker J. Pharmacokinetics of follicle-stimulating hormone: clinical significance. Fertil Steril. 1998;69:S40\u20139.","journal-title":"Fertil Steril"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fendo.2019.00429","volume":"10","author":"B Lunenfeld","year":"2019","unstructured":"Lunenfeld B, Bilger W, Longobardi S, Alam V, D\u2019Hooghe T, Sunkara SK. The development of gonadotropins for clinical use in the treatment of infertility. Front Endocrinol (Lausanne). 2019;10:429.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nbt.4305","volume":"36","author":"G Walsh","year":"2018","unstructured":"Walsh G. Biopharmaceutical benchmarks 2018. Nat Biotechnol. 2018;36:1136\u201345.","journal-title":"Nat Biotechnol"},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jcph.328","volume":"54","author":"H Olsson","year":"2014","unstructured":"Olsson H, Sandstr\u00f6m R, Grundemar L. Different Pharmacokinetic and pharmacodynamic properties of Recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non\u2010human cell line. J Clin Pharmacol. 2014;54:1299\u2013307.","journal-title":"J Clin Pharmacol"},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.3390\/ijms24109020","volume":"24","author":"M Lispi","year":"2023","unstructured":"Lispi M, Humaidan P, Bousfield GR, D\u2019Hooghe T, Ulloa-Aguirre A. Follicle-stimulating hormone biological products: does potency predict clinical efficacy? Int J Mol Sci. 2023;24:9020.","journal-title":"Int J Mol Sci"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","volume":"102","author":"J-C Arce","year":"2014","unstructured":"Arce J-C, Andersen AN, Fern\u00e1ndez-S\u00e1nchez M, Visnova H, Bosch E, Garc\u00eda-Velasco JA, Barri P, De Sutter P, Klein BM, Fauser BC. Ovarian response to Recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone\u2013stratified, dose\u2013response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2014;102:1633\u201340. e1635.","journal-title":"Fertil Steril"},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.rbmo.2022.03.034","volume":"45","author":"SM Gouveia","year":"2022","unstructured":"Gouveia SM, Lispi M, D\u2019Hooghe TM. Comparison between follitropin-delta and follitropin-alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms! Reprod Biomed Online. 2022;45:623\u20134.","journal-title":"Reprod Biomed Online"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/j.fertnstert.2020.08.907","volume":"114","author":"J-C Arce","year":"2020","unstructured":"Arce J-C, Larsson P. Establishing the follitropin delta dose providing comparable ovarian response as 150 IU\/day follitropin Alfa for controlled ovarian stimulation. Fertil Steril. 2020;114:e335\u20136.","journal-title":"Fertil Steril"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","volume":"126","author":"JW Song","year":"2010","unstructured":"Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126:2234\u201342.","journal-title":"Plast Reconstr Surg"},{"key":"1498_CR12","doi-asserted-by":"crossref","unstructured":"Schwarze J-E, Tennant PW, Barnhart K, Platt RW, Gupta S, Venetis C, D\u2019Hooghe T, Schisterman EF. Recommendation to improve the rigor and impact of non-randomized studies of interventions in fertility treatment research. Fertil Steril 2025.","DOI":"10.1016\/j.fertnstert.2025.05.168"},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejogrb.2015.08.031","volume":"194","author":"M Niinim\u00e4ki","year":"2015","unstructured":"Niinim\u00e4ki M, Veleva Z, Martikainen H. Embryo quality is the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles. Eur J Obstet Gynecol Reproductive Biology. 2015;194:131\u20135.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"1498_CR14","first-page":"76","volume":"16","author":"RD Rezaeiye","year":"2022","unstructured":"Rezaeiye RD, Mehrara A, Pour AMA, Fallahi J, Forouhari S. Impact of various parameters as predictors of the success rate of in vitro fertilization. Int J Fertility Steril. 2022;16:76.","journal-title":"Int J Fertility Steril"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1094428112447816","volume":"16","author":"M Li","year":"2013","unstructured":"Li M. Using the propensity score method to estimate causal effects: A review and practical guide. Organizational Res Methods. 2013;16:188\u2013226.","journal-title":"Organizational Res Methods"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"e000783","DOI":"10.1136\/bmjmed-2023-000783","volume":"3","author":"A-L Boulesteix","year":"2024","unstructured":"Boulesteix A-L, Hoffmann S. To adjust or not to adjust: it is not the tests performed that count, but how they are reported and interpreted. BMJ Med. 2024;3:e000783.","journal-title":"BMJ Med"},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/IJPSYM.IJPSYM_499_18","volume":"41","author":"C Andrade","year":"2019","unstructured":"Andrade C. Multiple testing and protection against a type 1 (False Positive) error using the bonferroni and Hochberg corrections. Indian J Psychol Med. 2019;41:99\u2013100.","journal-title":"Indian J Psychol Med"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01498-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01498-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01498-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:59:52Z","timestamp":1764604792000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01498-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01498-6","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Susana Montenegro, Juan-Enrique Schwarze and Sabrina de Souza are employees of Merck Healthcare KGaA, Darmstadt, Germany. Huan Zhang is an employee of Merck Serono Co., Ltd., Beijing, China, an affiliate of Merck KGaA, Darmstadt, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}